Tapewire

Nasdaq · USD

IRD

Opus Genetics, Inc.

Export transactions ↓
Tapewire entity
5892
SEC CIK
0001228627
Parsed reports
252

Last 12 months

Inside the activity.

2 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202521
Jan 202600
Feb 202600
Mar 202604
Apr 202606
May 202601
Jun 202600
Jul 202604
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 10, 2025 Filed Sep 11, 2025 22:03 UTC
Gagnon Robert E.Chief Financial Officer
GrantCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-003320 · form4.xml · nonDerivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

F1 · shares: Represents a grant of restricted stock units which vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.

Read SEC document
September 02, 2025 Filed Sep 11, 2025 22:03 UTC
Gagnon Robert E.Chief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 250,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0000905148-25-003320 · form4.xml · derivative · entry 2

Gagnon Robert E. · CIK 0001504983 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2035-09-01

F2 · derivative.exercise_date: The option will vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:15 UTC GrantCommon Stock 869,565 $1.15 $999,999.75
Disclosure

SEC source: 0000905148-25-003152 · form4.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,810,430

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:13 UTC GrantCommon Stock 86,956 $1.15 $99,999.40
Disclosure

SEC source: 0000905148-25-003151 · form4.xml · nonDerivative · entry 1

Ainsworth Sean · CIK 0001830296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,818

Read SEC document
May 05, 2025 Filed May 6, 2025 22:05 UTC
Foundation Fighting Blindness, Inc.Director · 10% owner · See Remarks
ConversionSeries A Non-Voting Convertible Preferred Stock · Derivative 6,927.419 Not disclosed Not disclosed
Disclosure

SEC source: 0001578563-25-000238 · primary_doc.xml · derivative · entry 2

Foundation Fighting Blindness Retinal Degeneration Fund · CIK 0002042266 · Director · 10% owner · See Remarks

Foundation Fighting Blindness, Inc. · CIK 0002042532 · Director · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,927,419 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A non-voting convertible preferred stock (the "Preferred Stock") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025.

F3 · price: The shares of Preferred Stock were issued to the Reporting Persons in connection with a merger and reorganization in a stock-for-stock transaction.

F1 · derivative.expiration_date: Each share of Series A non-voting convertible preferred stock (the "Preferred Stock") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025.

F2 · ownership.direct: Foundation Fighting Blindness, Inc. ("FFB") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund ("RDF") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold.

Read SEC document
May 05, 2025 Filed May 6, 2025 22:05 UTC
Foundation Fighting Blindness, Inc.Director · 10% owner · See Remarks
ConversionCommon Stock 6,927,419 Not disclosed Not disclosed
Disclosure

SEC source: 0001578563-25-000238 · primary_doc.xml · nonDerivative · entry 1

Foundation Fighting Blindness Retinal Degeneration Fund · CIK 0002042266 · Director · 10% owner · See Remarks

Foundation Fighting Blindness, Inc. · CIK 0002042532 · Director · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,492,171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A non-voting convertible preferred stock (the "Preferred Stock") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025.

F2 · ownership.direct: Foundation Fighting Blindness, Inc. ("FFB") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund ("RDF") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:03 UTC
Bennett JeanDirector
GrantStock Option (Right to Buy) · Derivative 79,592 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0000905148-25-001425 · form4.xml · derivative · entry 2

Bennett Jean · CIK 0001872219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,592

Underlying: Common Stock · 79,592 shares

Expires 2035-04-29

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:03 UTC
Bennett JeanDirector
GrantCommon Stock 79,504 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001425 · form4.xml · nonDerivative · entry 1

Bennett Jean · CIK 0001872219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,525

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 17:08 UTC GrantStock Option (Right to Buy) · Derivative 79,592 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0000905148-25-001429 · form4.xml · derivative · entry 2

MANUSO JAMES S J · CIK 0001236365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,592

Underlying: Common Stock · 79,592 shares

Expires 2035-04-29

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 17:08 UTC GrantCommon Stock 79,504 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001429 · form4.xml · nonDerivative · entry 1

MANUSO JAMES S J · CIK 0001236365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,763

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:06 UTC GrantStock Option (Right to Buy) · Derivative 79,592 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0000905148-25-001428 · form4.xml · derivative · entry 2

Graves Adrienne L · CIK 0001326192 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,592

Underlying: Common Stock · 79,592 shares

Expires 2035-04-29

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:06 UTC GrantCommon Stock 79,504 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001428 · form4.xml · nonDerivative · entry 1

Graves Adrienne L · CIK 0001326192 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,504

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:09 UTC GrantStock Option (Right to Buy) · Derivative 79,592 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0000905148-25-001430 · form4.xml · derivative · entry 2

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,592

Underlying: Common Stock · 79,592 shares

Expires 2035-04-29

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:09 UTC GrantCommon Stock 79,504 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001430 · form4.xml · nonDerivative · entry 1

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 318,655

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:05 UTC GrantStock Option (Right to Buy) · Derivative 79,592 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0000905148-25-001427 · form4.xml · derivative · entry 2

Gallagher Cam · CIK 0001557832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,592

Underlying: Common Stock · 79,592 shares

Expires 2035-04-29

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:05 UTC GrantCommon Stock 79,504 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001427 · form4.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 940,865

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:02 UTC GrantStock Option (Right to Buy) · Derivative 79,592 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0000905148-25-001424 · form4.xml · derivative · entry 2

Ainsworth Sean · CIK 0001830296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,592

Underlying: Common Stock · 79,592 shares

Expires 2035-04-29

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:02 UTC GrantCommon Stock 79,504 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001424 · form4.xml · nonDerivative · entry 1

Ainsworth Sean · CIK 0001830296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,862

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:04 UTC
Benton SusanDirector
GrantStock Option (Right to Buy) · Derivative 79,592 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0000905148-25-001426 · form4.xml · derivative · entry 2

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,592

Underlying: Common Stock · 79,592 shares

Expires 2035-04-29

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:04 UTC
Benton SusanDirector
GrantCommon Stock 79,504 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001426 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,527

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 20:10 UTC
Magrath GeorgeDirector · Chief Executive Officer
GrantWarrants (right to buy) · Derivative 392,157 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0000905148-25-001007 · form4.xml · derivative · entry 2

Magrath George · CIK 0001999390 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,157

Underlying: Common Stock · 392,157 shares

Expires 2030-03-24

F1 · kind: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.

F1 · price: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.

F2 · derivative.exercise_date: These warrants are immediately exercisable and may be called by the Issuer at any time starting with 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's common stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 20:10 UTC
Magrath GeorgeDirector · Chief Executive Officer
GrantCommon Stock 392,157 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-25-001007 · form4.xml · nonDerivative · entry 1

Magrath George · CIK 0001999390 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,322,004

F1 · kind: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.

F1 · price: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 20:08 UTC GrantWarrants (right to buy) · Derivative 784,314 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0000905148-25-001006 · form4.xml · derivative · entry 2

Gallagher Cam · CIK 0001557832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 784,314

Underlying: Common Stock · 784,314 shares

Expires 2030-03-24

F1 · kind: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.

F1 · price: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.

F2 · derivative.exercise_date: These warrants are immediately exercisable and may be called by the Issuer at any time starting with 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's common stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 20:08 UTC GrantCommon Stock 784,314 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-25-001006 · form4.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 861,361

F1 · kind: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.

F1 · price: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:56 UTC
SCHACHLE JOSEPH KChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 52,500 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000905148-25-000942 · form4.xml · derivative · entry 2

SCHACHLE JOSEPH K · CIK 0001145914 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 52,500 shares

Expires 2035-03-12

F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:56 UTC
SCHACHLE JOSEPH KChief Operating Officer
GrantCommon Stock 52,500 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-000942 · form4.xml · nonDerivative · entry 1

SCHACHLE JOSEPH K · CIK 0001145914 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,500

F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:52 UTC
Jhaveri Nirav S.Chief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 52,500 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000905148-25-000939 · form4.xml · derivative · entry 2

Jhaveri Nirav S. · CIK 0002011481 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 52,500 shares

Expires 2035-03-12

F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:52 UTC
Jhaveri Nirav S.Chief Financial Officer
GrantCommon Stock 52,500 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-000939 · form4.xml · nonDerivative · entry 1

Jhaveri Nirav S. · CIK 0002011481 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,293

F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:50 UTC
Jayagopal AshwathChief Scientific & Dev. Ofc.
GrantEmployee Stock Option (right to buy) · Derivative 52,500 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000905148-25-000938 · form4.xml · derivative · entry 2

Jayagopal Ashwath · CIK 0002008983 · Chief Scientific & Dev. Ofc.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 52,500 shares

Expires 2035-03-12

F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:50 UTC
Jayagopal AshwathChief Scientific & Dev. Ofc.
GrantCommon Stock 52,500 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-000938 · form4.xml · nonDerivative · entry 1

Jayagopal Ashwath · CIK 0002008983 · Chief Scientific & Dev. Ofc.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,807

F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:53 UTC
Magrath GeorgeChief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 330,697 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000905148-25-000940 · form4.xml · derivative · entry 2

Magrath George · CIK 0001999390 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,697

Underlying: Common Stock · 330,697 shares

Expires 2035-03-12

F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:53 UTC
Magrath GeorgeChief Executive Officer
GrantCommon Stock 330,697 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-000940 · form4.xml · nonDerivative · entry 1

Magrath George · CIK 0001999390 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 929,847

F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:49 UTC
Hoffmann BernhardSVP of Corp. Dev.
GrantEmployee Stock Option (right to buy) · Derivative 29,500 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000905148-25-000937 · form4.xml · derivative · entry 2

Hoffmann Bernhard · CIK 0001830354 · SVP of Corp. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,500

Underlying: Common Stock · 29,500 shares

Expires 2035-03-12

F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:49 UTC
Hoffmann BernhardSVP of Corp. Dev.
GrantCommon Stock 29,500 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-000937 · form4.xml · nonDerivative · entry 1

Hoffmann Bernhard · CIK 0001830354 · SVP of Corp. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,446

F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:54 UTC
Zaremba Rabourn AmySVP of Finance
GrantEmployee Stock Option (right to buy) · Derivative 39,500 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000905148-25-000941 · form4.xml · derivative · entry 2

Zaremba Rabourn Amy · CIK 0001832343 · SVP of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,500

Underlying: Common Stock · 39,500 shares

Expires 2035-03-12

F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.

Read SEC document
March 13, 2025 Filed Mar 18, 2025 00:54 UTC
Zaremba Rabourn AmySVP of Finance
GrantCommon Stock 39,500 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-000941 · form4.xml · nonDerivative · entry 1

Zaremba Rabourn Amy · CIK 0001832343 · SVP of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,968

F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:05 UTC
Jhaveri Nirav S.Chief Financial Officer
Tax withholdingCommon Stock 8,207 $1.15 $9,438.05
Disclosure

SEC source: 0000905148-25-000713 · form4.xml · nonDerivative · entry 1

Jhaveri Nirav S. · CIK 0002011481 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,793

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:04 UTC
Jayagopal AshwathChief Scientific & Dev. Ofc.
Tax withholdingCommon Stock 5,193 $1.15 $5,971.95
Disclosure

SEC source: 0000905148-25-000712 · form4.xml · nonDerivative · entry 1

Jayagopal Ashwath · CIK 0002008983 · Chief Scientific & Dev. Ofc.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,307

Read SEC document
February 04, 2025 Filed Feb 6, 2025 21:37 UTC
Zaremba Rabourn AmySVP of Finance
Tax withholdingCommon Stock 8,190 $1.14 $9,336.60
Disclosure

SEC source: 0000905148-25-000403 · form4.xml · nonDerivative · entry 1

Zaremba Rabourn Amy · CIK 0001832343 · SVP of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,468

Read SEC document
February 04, 2025 Filed Feb 6, 2025 21:35 UTC
Hoffmann BernhardSVP of Corp. Dev.
Tax withholdingCommon Stock 6,751 $1.14 $7,696.14
Disclosure

SEC source: 0000905148-25-000401 · form4.xml · nonDerivative · entry 1

Hoffmann Bernhard · CIK 0001830354 · SVP of Corp. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,946

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:42 UTC
Bennett JeanDirector
GrantCommon Stock 34,021 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-25-000038 · form4.xml · nonDerivative · entry 1

Bennett Jean · CIK 0001872219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,021

F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for 2025. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock on the grant date (rounded down to the nearest whole share). The average fair market value was $1.23 per share, the average of the high and low price of the common stock on the date of grant.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 16:43 UTC GrantCommon Stock 50,222 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-25-000039 · form4.xml · nonDerivative · entry 1

MANUSO JAMES S J · CIK 0001236365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,259

F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for 2025. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock on the grant date (rounded down to the nearest whole share). The average fair market value was $1.23 per share, the average of the high and low price of the common stock on the date of grant.

Read SEC document
December 26, 2024 Filed Dec 30, 2024 21:26 UTC
Magrath GeorgeChief Executive Officer
PurchaseCommon Stock 100,000 $0.98 $97,600.00
Disclosure

SEC source: 0000905148-24-003425 · form4.xml · nonDerivative · entry 1

Magrath George · CIK 0001999390 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 599,150

F1 · price: The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.97 to $0.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
December 23, 2024 Filed Dec 23, 2024 22:50 UTC
Magrath GeorgeChief Executive Officer
GrantCommon Stock 6,200 $0.00 $0.00
Disclosure

SEC source: 0000905148-24-003406 · form4.xml · nonDerivative · entry 1

Magrath George · CIK 0001999390 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 499,150

F1 · kind: These shares were issued to the Reporting Person to correct an inadvertent over-withholding of shares on November 1, 2024, in connection with the vesting of restricted stock units on that date.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:18 UTC
YERXA BENJAMIN RDirector · President
PurchaseCommon Stock 10,000 $0.98 $9,834.00
Disclosure

SEC source: 0000905148-24-003268 · form4.xml · nonDerivative · entry 1

YERXA BENJAMIN R · CIK 0001145910 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342,800

Read SEC document
November 18, 2024 Filed Nov 19, 2024 21:08 UTC
Magrath GeorgeChief Executive Officer
PurchaseCommon Stock 9,706 $1.02 $9,942.83
Disclosure

SEC source: 0000905148-24-003236 · form4.xml · nonDerivative · entry 2

Magrath George · CIK 0001999390 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 492,950

F2 · price: The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.005 to $1.06, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 21:08 UTC
Magrath GeorgeChief Executive Officer
PurchaseCommon Stock 90,294 $1.01 $91,215.00
Disclosure

SEC source: 0000905148-24-003236 · form4.xml · nonDerivative · entry 1

Magrath George · CIK 0001999390 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 483,244

F1 · price: The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.975 to $1.05, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 21:35 UTC
YERXA BENJAMIN RDirector · President
GrantCommon Stock 332,800 $0.00 $0.00
Disclosure

SEC source: 0000905148-24-003015 · form4.xml · nonDerivative · entry 1

YERXA BENJAMIN R · CIK 0001145910 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,800

F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third, and fourth anniversary of October 22, 2024, subject to the Reporting Person's continuing service.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:13 UTC
Magrath GeorgeChief Executive Officer
Tax withholdingCommon Stock 37,050 $1.18 $43,719.00
Disclosure

SEC source: 0000905148-24-002934 · form4.xml · nonDerivative · entry 1

Magrath George · CIK 0001999390 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,950

Read SEC document
October 22, 2024 Filed Oct 24, 2024 21:56 UTC
Bennett JeanDirector
GrantStock Option (right to buy) · Derivative 172,874 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0000905148-24-002827 · form4.xml · derivative · entry 2

Bennett Jean · CIK 0001872219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,874

Underlying: Common Stock · 172,874 shares

Expires 2034-10-21

F2 · derivative.exercise_date: The option will vest in a series of three equal annual installments over the three-year period measured from the grant date of October 22, 2024, subject to the Reporting Person's continuing service.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.